Skip to Content

MD Anderson Events

CPC Grand Rounds - Identifying Molecular Targets And Developing Novel Anti-Cancer Therapy For Breast Cancer Prevention And Treatment

CPC Grand Rounds - Identifying Molecular Targets And Developing Novel Anti-Cancer Therapy For Breast Cancer Prevention And Treatment

 The Division of Cancer Prevention and Population Sciences, Cancer Prevention & Control Grand Rounds presents Dr. Qiang Shen, Associate Professor in the Department of Clinical Cancer Prevention, at The University of Texas MD Anderson Cancer Center, on Friday, February 16, 2018.

Date: 2/16/18, 12pm to 1pm
Time: 2/16/18, 12pm to 1pm
Location: Duncan Building, CPB8 Rooms 7 & 8, Floor 8, Elevator Q
Format: Grand Rounds
CME: 1 CME & 1 CHES/MCHES Credit
Speaker: Dr. Qiang Shen
Speaker Bio: Dr. Qiang Shen received his medical education in Jiangxi Medical College and Kunming Medical University in China and practiced medicine for a number of years. Then he obtained a Ph.D. degree in Cell Biology from the University of Texas Medical Branch in 2002. After that, he was trained as a Postdoctoral Fellow at Baylor College of Medicine Breast Center with Dr Powel Brown in the areas of breast cancer biology and molecular cancer prevention from 2002 to 2006. He was promoted to Instructor at Baylor from 2006 to 2009 in the Department of Molecular & Cellular Biology and the Department of Medicine. Dr. Shen joined MD Anderson in November 2009 as a tenure-track Assistant Professor in the Department of Clinical Cancer Prevention. He was promoted to tenure Associate Professor in 2017. Dr Shen studies transcription factors including AP-1 and STAT3, kinases such HIPK4, glucose metabolism enzymes, and ion channels in the development and metastasis of breast and other cancers. He has published more than 60 peer-reviewed research articles in career, and is a co-inventor of two patents. Dr Shen received many awards and honors in career, and served in 5 study sections as grant reviewer, in addition to serving as reviewer for more than 30 journals and editor for 12 journals. His research has been supported by MD Anderson Startup Funds, IRG, and DFI Grants; Prevent Cancer Foundation Grant; American Cancer Society Research Scholar Grant; DOD BCRP Grant; NCI PREVENT Program Fund; and K22, SBIR, and R01 Grants from NIH/NCI.
Contact: Jennifer Tijerina - (832) 750-1629 - jmcastillo1@mdanderson.org